Ahmed Aly Hussein Aly

MD
Urology
Buffalo Spree Top Doctor 2024

Dr. Hussein Aly is a Buffalo Spree Top Doctor! See all of our physicians who made this year's list.

Top Doctors 2024

Cancers Treated:

Research Interests:

Active Surveillance for Prostate Cancer Functional Outcomes After Robotic Prostatectomy Outcomes of Robotic Cystectomy Artificial Intelligence in Medicine

About Ahmed Aly Hussein Aly

Biography:

Dr. Aly was appointed to the faculty at Roswell Park Comprehensive Cancer Center in 2020. He serves in the Department of Urology and in the Applied Technology Laboratory for Advanced Surgery (ATLAS) program.

Dr. Aly attended Cairo University School of Medicine in Cairo, Egypt where he earned his medical degree (2007). He subsequently completed his internship in Surgery and Medicine (2008) and residency in Urology (2012) at Cairo University Hospitals in Egypt. He completed a Pediatric Urology Fellowship in Cairo University (2013) and the Membership of the Royal College of Surgeons (MRCS) of London, United Kingdom (2013).

Dr. Aly was awarded the prestigious Société Internationale d’Urologie-University of California, San Francisco (SIU-UCSF) research fellowship in Urologic Oncology (2014). He joined the Urologic Oncology fellowship program at Roswell Park Comprehensive Cancer Center in 2015, first as a research fellow then as a clinical fellow. He completed the Society of Urologic Oncology (SUO) fellowship in 2019.

Dr. Aly specializes in the care of patients genitourinary cancers and provides expertise in both robot-assisted and open operative approaches. Dr. Aly also provides care for complications associated with radical cancer surgery, including erectile dysfunction and urinary incontinence.

Dr. Aly has authored and co-authored more than 100 peer-reviewed publications, in addition to many book chapters and abstracts on genitourinary oncology topics. He serves as a reviewer for multiple journals, including European Urology, The Journal of Urology, Urology Practice, Urologic Oncology, and others.

Dr. Aly is a member of the American Urologic Association (AUA), Society of Urologic Oncology (SUO), Egyptian Urological Association (EUA), Societie Internationale d’Urologie (SIU) and Royal College of Surgeons, UK (RCS).

Positions

Roswell Park Comprehensive Cancer Center
  • Assistant Professor of Oncology
  • Academic Clinical Associate
  • Department of Urology

Roswell Park Care Network

  • Roswell Park Niagara Falls Boulevard

Background

Education and Training:

  • 2013 - M.R.C.S Surgery, Royal College of Surgeons, United Kingdom
  • 2012 - MS - Urology and Andrology, Cairo University, Medical School, Egypt
  • 2007 - MD - Cairo University Medical School, Egypt

Residency:

  • 2008-2012 - Urology - Cairo University Hospitals in Egypt

Fellowship:

  • 2017-2019 - Society of Urologic Oncology (SUO) fellowship, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • 2015-2017 - Research and Clinical fellowship in Urologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • 2014 - Research fellowship in Urologic Oncology, Société Internationale d’Urologie-University of California, San Francisco, CA
  • 2013 - Pediatric Urology Fellowship, Cairo University, Cairo, Egypt

Professional Memberships:

  • American Urologic Association (AUA)
  • Society of Urologic Oncology (SUO)
  • European Association of Urology (EAU)
  • Egyptian Urological Association (EUA)
  • Societie Internationale d’Urologie (SIU)
  • Royal College of Surgeons, UK (RCS)

Professional Experience:

  • 2015-2020 - Fellow, Roswell Park Comprehensive Cancer Center, Buffalo, NY
  • 2014-2015 - Research Fellow, University of California, San Francisco, CA
  • 2013-2014 - Assistant Lecturer of Urology, Cairo University, Egypt
  • 2012-2013 - Demonstrator of Urology, Cairo University, Egypt
  • 2009-2012 - Urology resident, Kasr Al-Ainy Hospitals, Cairo University, Egypt
  • 2008-2009 - General Surgery resident, Kasr Al-Ainy Hospitals, Cairo University, Egypt
  • 2007-2008 - House Officer, Kasr Al-Ainy Hospitals, Cairo University, Egypt

Honors & Awards:

  • American Urological Association 2023 - Best video
  • American Urologic Association 2020 - Best video
  • American Urologic Association 2019 - Best video
  • American Urologic Association 2019 - Best poster
  • American Urologic Association 2018 - Best poster
  • World Congress of Endourology 2017 - Best Poster
  • American Urologic Association 2016 - Best poster
  • 2014 - Société Internationale d’Urologie-University of California (SIU-UCSF) research fellowship
  • 2013 - European-Arab School (EASO) Travel Scholarship
  • 2013 - Société Internationale d’Urologie (SIU) resident scholarship
  • 2012- Société Internationale d’Urologie (SIU) resident scholarship
  • 2007 - Excellence with Honors, Final Year, Cairo University Medical School, Egypt

Research

Research Overview:

Dr. Aly's research focuses on improving the outcomes of patients with blood cancer, including outcomes of robot-assisted radical cystectomy, investigating alternative treatments for non-muscle invasive bladder cancer, as well as investigating the bladder cancer-associated microbiome.

Dr. Aly's research interests also include improving the quality of life of patients with prostate cancer, and applications of artificial intelligence in Urology.


Featured on Cancer Talk


Publications

Full Publications list on PubMed

1. Hussein AA, Shabir U, Mahmood A, Harrington G, Khan M, Ahmad A, Howlader M, Colan N, Shah A, Ghaderoshi S, Jing Z, Xu B, Sule N, Azabdaftari G, Kauffman EC, Kuettel M, Guru KA. Impact of a NCCN Compliant Multidisciplinary Conference on the Uptake of Active Surveillance Among Eligible Patients with Localized Prostate Cancer. Urologic Oncology 2023. 41(12):483.e21-483.e26. PMID: 37945390.

2. Hussein AA, Bhat TA, Jing Z, Gomes EC, Mahmood A, Singh PK, Liu S, Smith G, Huru KA. Does the Urinary Microbiome Profile Change After Treatment of Bladder Cancer? World Journal of Urology. 2023. (12):3593-3598. PMID: 37796319

3. Daza J, Ahmad A, Shabir U, Jing Z, Sheikh M, Kauffman E, Guru KA, Hussein AA. Does Testosterone Replacement Therapy Increase the Risk of Conversion to Treatment in Patients with Prostate Cancer on Active Surveillance? Urologic Oncology, 2023. (10):429.e1-429.e7. PMID: 37423815

4. Hussein AA, Smith, G, Guru KA. The Association between the Urinary Microbiome and Bladder Cancer. Urologic Clinics of North America, 2023. 50 (1) 1-160. PMID: 36424085

5. Hussein AA, Iqbal U, Jing Z, Ramahi YO, Houenstein H, Newman S, Peterson B, Krajacic K, Samoni A, Xu B, Sule N, Azabdaftari G, Kauffman EC, Mohler J, Kuettel M, Guru KA. Impact of a NCCN Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer. JNCCN, 2023. 21(4):359-365.e4. PMID: 37015336.